Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine as an adjuvant to intrapleural ropivacaine after video-assisted thoracoscopic surgery
ChiCTR1900022886Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- May 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine and ropivacaine in postoperative pain (2 arms), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Primary endpoint: Duration of analgesic effect after pleural cavity injection. Planned start May 2019; status: not yet recruiting.
02
Drugs
dexmedetomidineropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR1900022886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022886.